• Explore /
  • Poster
  • / A phase II study of intratumoral administration of the autologous immature dendritic cell (DC) vaccine used after lesion photodynamic therapy (PhDT) and immunomodulation with cyclophosphamide (Cy) in pretreated patients with disseminated malignant melanoma.

A phase II study of intratumoral administration of the autologous immature dendritic cell (DC) vaccine used after lesion photodynamic therapy (PhDT) and immunomodulation with cyclophosphamide (Cy) in pretreated patients with disseminated malignant melanoma.

Abstract Poster

Authors

null

Alexey Viktorovich Novik

N. N. Petrov Research Institute of Oncology, St. Petersburg, Russia

Alexey Viktorovich Novik , Irina Alexandrovma Baldueva , Mark Lvovich Gelfond , Svetlana Protsenko , Tatyana Leonidovna Nehaeva , Andrei Ivanovich Waal , Eugene Vladimirovich Vorobeychikov , Anna Borisovna Danilova , Alexey Olegovich Danilov , Anna Igorevna Semenova , Gulfiya Midhatovna Teletaeva , Vladimir Moiseyenko

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics - Immunotherapy

Track

Developmental Therapeutics

Sub Track

Vaccines

Citation

J Clin Oncol 31, 2013 (suppl; abstr 3088)

DOI

10.1200/jco.2013.31.15_suppl.3088

Abstract #

3088

Poster Bd #

19G

Abstract Disclosures

Similar Posters

First Author: José María López-Picazo

First Author: Yuk Ting Ma

First Author: Dmitriy Zamarin

First Author: Adi Diab